SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 144 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $286,688 | -63.1% | 12,400 | -58.1% | 0.00% | -50.0% |
Q2 2023 | $776,112 | -68.9% | 29,600 | -69.4% | 0.00% | -66.7% |
Q1 2023 | $2,491,632 | -38.1% | 96,800 | -37.4% | 0.01% | -45.5% |
Q4 2022 | $4,023,747 | -7.8% | 154,700 | +1.1% | 0.01% | -15.4% |
Q3 2022 | $4,365,000 | +19.5% | 153,000 | +3.1% | 0.01% | +30.0% |
Q2 2022 | $3,654,000 | +73.4% | 148,400 | +336.5% | 0.01% | +100.0% |
Q4 2021 | $2,107,000 | +7.8% | 34,000 | +10.4% | 0.01% | 0.0% |
Q3 2021 | $1,954,000 | +347.1% | 30,800 | +481.1% | 0.01% | +400.0% |
Q2 2021 | $437,000 | -58.2% | 5,300 | -62.7% | 0.00% | -66.7% |
Q1 2021 | $1,045,000 | – | 14,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |